))
Therapy Evaluation: T2DM, HTN, Dyslipidaemia, CKD
Manage episode 361008642 series 3456065
Kandungan disediakan oleh Fitzgerald Health Education Associates. Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh Fitzgerald Health Education Associates atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.
The NP is caring for a 68 year-old man with a 20 year-history of type 2 DM, HTN, dyslipidaemia, obesity (BMI=32 kg/m2) stage 3a CKD who is currently taking all of the following medications at optimized doses and with adherence, ACEI, thiazide diuretic, statin, and metformin. His current A1c= 8.2%. (NL= <5-6%) and states he is feeling well. Which of the following should be considered as next step therapy?
A. A sulfonylurea
B. Basal insulin
C. A SGLT2- inhibitor
D. No additional therapy as he is feeling well.
---
YouTube: https://www.youtube.com/watch?v=SF_ztpgR_Tw&list=PLf0PFEPBXfq592b5zCthlxSNIEM-H-EtD&index=14
Visit fhea.com to learn more!
64 episod
Kongsi
